Topical Fluticasone Propionate Versus Fusidic Acid for Zoon’s Balanitis in Men: A Prospective, Open-Label, Non-Randomised Comparative Study with an Exploratory Long-Term Assessment
Journal of Clinical Medicine · 02.11.2026 · 15 (21) · 8515
DOI: 10.3390/jcm15218515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.11.2026. Verfasst von Katarzyna Czajkowska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venerology and Allergology, Medical University of Gdańsk, Mariana Smoluchowskiego 17, 80-214 Gdańsk, Poland. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prospective comparative evidence for topical treatment of Zoon’s balanitis is limited. We evaluated early clinical changes during two topical regimens and explored recorded long-term outcomes.
Methods
In this single-centre, prospective, open-label, non-randomised study, 37 men with histopathologically confirmed Zoon’s balanitis were allocated by alternation to fluticasone propionate 0.05% (n = 18) or fusidic acid 2% (n = 19) for four weeks. Early assessments used a four-point study Investigator’s Global Assessment (IGA) and symptom visual analogue scales. Additional exploratory comparisons included IGA 0 at week 4. A separate categorical assessment was undertaken in 2026. The study was not registered in a public clinical-trial registry.
Results
Mean IGA decreased from 2.17 to 0.67 with fluticasone and from 2.26 to 0.89 with fusidic acid between baseline and week 4. Complete clearance occurred in 8/18 (44.4%) and 6/19 (31.6%) participants, respectively; the absolute difference was 12.9 percentage points (95% confidence interval, −17.1 to 40.1; Fisher’s exact p = 0.50768). Among participants assessable in 2026, recorded remission occurred in 12/16 (75.0%) and 3/15 (20.0%), respectively (unadjusted odds ratio, 12.00; approximate 95% confidence interval, 2.20–65.52; p = 0.00385). These data did not establish uninterrupted or treatment-free remission; missing-outcome sensitivity analyses limited the robustness of the association.
Conclusions
Clinical severity improved during both regimens, but comparative equivalence was not established. The association between initial fluticasone allocation and recorded remission in 2026 is hypothesis-generating and requires confirmation in a registered, adequately powered controlled study with standardised long-term assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venerology and Allergology, Medical University of Gdańsk, Mariana Smoluchowskiego 17, 80-214 Gdańsk, Poland.
- Department of Urology, Medical University of Gdańsk, Mariana Smoluchowskiego 17, 80-214 Gdańsk, Poland.
ORCID-Profile: Katarzyna Czajkowska, Mateusz Czajkowski, Roman Janusz Nowicki, Małgorzata Sokołowska-Wojdyło
Zitieren
APA
Czajkowska, K., Czajkowski, M., Nowicki, R. J., Matuszewski, M., & Sokołowska-Wojdyło, M. (2026). Topical Fluticasone Propionate Versus Fusidic Acid for Zoon’s Balanitis in Men: A Prospective, Open-Label, Non-Randomised Comparative Study with an Exploratory Long-Term Assessment. Journal of Clinical Medicine, 15(21), 8515. https://doi.org/10.3390/jcm15218515
Vancouver
Czajkowska K, Czajkowski M, Nowicki RJ, Matuszewski M, Sokołowska-Wojdyło M. Topical Fluticasone Propionate Versus Fusidic Acid for Zoon’s Balanitis in Men: A Prospective, Open-Label, Non-Randomised Comparative Study with an Exploratory Long-Term Assessment. Journal of Clinical Medicine. 2026;15(21):8515. doi:10.3390/jcm15218515
BibTeX
@article{Czajkowska2026,
author = {Czajkowska, Katarzyna and Czajkowski, Mateusz and Nowicki, Roman Janusz and Matuszewski, Marcin and Sokołowska-Wojdyło, Małgorzata},
title = {Topical Fluticasone Propionate Versus Fusidic Acid for Zoon’s Balanitis in Men: A Prospective, Open-Label, Non-Randomised Comparative Study with an Exploratory Long-Term Assessment},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8515},
doi = {10.3390/jcm15218515}
}
EUVIMED